Literature DB >> 8647959

T cell receptor biases and clonal proliferations among lung transplant recipients with obliterative bronchiolitis.

S R Duncan1, V Valentine, M Roglic, D J Elias, K W Pekny, J Theodore, D H Kono, A N Theofilopoulos.   

Abstract

Obliterative bronchiolitis (OB) is the most serious late complication of lung transplantation, but the pathogenesis of this disorder has not been elucidated. We sought evidence that OB is mediated by a cellular immunologic response by characterizing T cell antigen receptor beta-chain variable gene (TCRBV) repertoires in lung allograft recipients. Expression levels of 27 TCRBV among recipients were determined by multiprobe RNase protection assay after PCR amplification. In comparison to recipients with no evidence of rejection (n = 9), the PBL TCRBV repertoires of OB subjects (n = 16) exhibited more frequent expansions (16 vs. 9% of all measured TCRBV, P < 0.02), and the magnitudes of these abnormalities were greater (8.2 +/- 0.8 vs. 4.5 +/- 0.3 SD from mean normal values, P < 0.01). TCRBV sequencing showed these expansions were composed of clonal or oligoclonal populations. Thus, T cell responses in the recipients are marked by highly selective clonal expansions, presumably driven by indirect recognition of a limited number of immunodominant alloantigens. These processes are exaggerated among allograft recipients with OB, implying that cognate immune mechanisms are important in the pathogenesis of the disorder. Furthermore, the prominence of finite, distinct TCR phenotypes raise possibilities for development of novel diagnostic modalities and targeted immunotherapies for OB and other manifestations of chronic allograft rejection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647959      PMCID: PMC507352          DOI: 10.1172/JCI118714

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

Review 1.  The V-region disease hypothesis: evidence from autoimmune encephalomyelitis.

Authors:  E Heber-Katz; H Acha-Orbea
Journal:  Immunol Today       Date:  1989-05

Review 2.  T-lymphocyte-antigen interactions in transplant rejection.

Authors:  A M Krensky; A Weiss; G Crabtree; M M Davis; P Parham
Journal:  N Engl J Med       Date:  1990-02-22       Impact factor: 91.245

Review 3.  Cellular and molecular mechanisms of allograft rejection.

Authors:  R B Colvin
Journal:  Annu Rev Med       Date:  1990       Impact factor: 13.739

Review 4.  Obliterative bronchiolitis.

Authors:  J Theodore; V A Starnes; N J Lewiston
Journal:  Clin Chest Med       Date:  1990-06       Impact factor: 2.878

5.  Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens?

Authors:  P Matzinger; M J Bevan
Journal:  Cell Immunol       Date:  1977-03-01       Impact factor: 4.868

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  Selection of amino acid sequences in the beta chain of the T cell antigen receptor.

Authors:  S M Hedrick; I Engel; D L McElligott; P J Fink; M L Hsu; D Hansburg; L A Matis
Journal:  Science       Date:  1988-03-25       Impact factor: 47.728

8.  T cell receptor beta-chain selection in human allograft rejection.

Authors:  M C Miceli; O J Finn
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

9.  Clonal analysis of graft-infiltrating lymphocytes from renal and cardiac biopsies. Dominant rearrangements of TcR beta genes and persistence of dominant rearrangements in serial biopsies.

Authors:  D M Frisman; A A Hurwitz; W T Bennett; L A Boyle; J T Fallon; G W Dec; R B Colvin; J T Kurnick
Journal:  Hum Immunol       Date:  1990-06       Impact factor: 2.850

10.  Identification of clonally expanded T cells in rheumatoid arthritis using a sequence enrichment nuclease assay.

Authors:  R González-Quintial; R Baccalá; R M Pope; A N Theofilopoulos
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

View more
  7 in total

1.  CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients.

Authors:  Sean M Studer; M Patricia George; Xuehai Zhu; Yifang Song; Vincent G Valentine; Michael W Stoner; Jigme Sethi; Chad Steele; Steven R Duncan
Journal:  Am J Respir Crit Care Med       Date:  2008-07-10       Impact factor: 21.405

2.  Inhaled cyclosporine and pulmonary function in lung transplant recipients.

Authors:  Soleyah Groves; Marek Galazka; Bruce Johnson; Timothy Corcoran; Avelino Verceles; Edward Britt; Nevins Todd; Bartley Griffith; Gerald C Smaldone; Aldo Iacono
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-02       Impact factor: 2.849

3.  Thymic dendritic cells traffic to thymi of allogeneic recipients and prolong graft survival.

Authors:  Steven R Duncan; Nickolas G Capetanakis; Brian R Lawson; Argyrios N Theofilopoulos
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

4.  Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12.

Authors:  H N Lode; R Xiang; S R Duncan; A N Theofilopoulos; S D Gillies; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

5.  FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts.

Authors:  Aya Miyagawa-Hayashino; Tatsuaki Tsuruyama; Hiroto Egawa; Hironori Haga; Hiromi Sakashita; Tomoko Okuno; Shinya Toyokuni; Keiji Tamaki; Hirohiko Yamabe; Toshiaki Manabe; Shinji Uemoto
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

Review 6.  Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.

Authors:  Jason W Chien; Steven Duncan; Kirsten M Williams; Steven Z Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2009-11-05       Impact factor: 5.742

7.  A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation.

Authors:  Aldo Iacono; Marniker Wijesinha; Keshava Rajagopal; Natalia Murdock; Irina Timofte; Bartley Griffith; Michael Terrin
Journal:  ERJ Open Res       Date:  2019-10-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.